Counterpoint: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

Oncology (Williston Park). 2019 Jun 19;33(6):235, 237-8, 242.
No abstract available

MeSH terms

  • Gene Expression Profiling
  • Humans
  • Male
  • Molecular Imaging / methods
  • Neoplasm Grading
  • Population Surveillance / methods
  • Prognosis
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / diagnostic imaging
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / pathology*
  • Risk Assessment / methods
  • Watchful Waiting / methods*
  • Watchful Waiting / statistics & numerical data
  • Watchful Waiting / trends